Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-23, Stock:ABBV, The news for the past five days is as follows:
2021-11-16: NEWS1: Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion.
2021-11-17: NEWS1: Europe Approves AbbVie's Skyrizi For Second Indication.NEWS2: 1 Dividend Stock to Help You Fight Inflation.NEWS3: Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows.NEWS4: AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis.
2021-11-18: NEWS1: AbbVie's (ABBV) Skyrizi Gets Nod for Psoriatic Arthritis in EU.NEWS2: Pharma Stock Roundup: JNJ to Spin Off Consumer Unit, PFE Eyes EUA for COVID Pill.NEWS3: New Literature Review Highlights Economic Benefits Associated with Achieving Rheumatoid Arthritis Remission.NEWS4: 10 Dividend Stocks to Buy According to Greg Eisner’s Engineers Gate Manager.NEWS5: Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3.NEWS6: AbbVie Announces First Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with Previously Untreated Chronic Lymphocytic Leukemia in Quebec.
2021-11-19: NEWS1: Pfizer (PFE) Inks $5.3B COVID Pill Supply Deal With U.S..NEWS2: Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting.
2021-11-22: NEWS1: 7 High-Yield Stock Gems for Income-Obsessed Investors.

Answer: Rise